高级检索
当前位置: 首页 > 详情页

Effectiveness comparisons of catgut implantation at acupoint for obese type 2 diabetes: A protocol for systematic review and meta analysis.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [a]Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Shenzhen, Guangdong Province, [b]Changchun University of Chinese Medicine, Changchun, Jilin Province, [c]The Third Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, China.
出处:
ISSN:

关键词: Acupoint catgut embedding obese type 2 diabetes protocol systematic review

摘要:
With the change of people's life style, many more people are suffering from obese type 2 diabetes mellitus (T2DM). Acupoint catgut embedding is one of the acupuncture treatment principles in traditional Chinese medicine, which is widely used in the treatment of obese T2DM. However, there is no systematic review of the therapeutic effect of acupoint catgut embedding on obesity T2DM. Therefore, this article aims at the meta-analysis of acupoint catgut embedding in the treatment of obese T2DM, to clarify its curative effect. A structured and systemic literature search was conducted in the following databases up to December 1, 2019: PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, EMBASE, CNKI, Wanfang Database. We will use the Review Manager 5.3 software provided by Cochrane collaborative network for statistical analysis. Then we assessed the quality and risk of the included studies and observed the outcome measures. This meta-analysis will further determine the beneficial efficacy of acupoint catgut embedding on obesity T2DM. The purpose of this meta-analysis is to explore the effect of acupoint catgut embedding intervention on obese T2DM patients, and provide more options for clinicians and patients to treat obese T2DM. This systemic review will evaluate the efficacy and safety of acupoint catgut embedding in the treatment of obesity T2DM. Since all the data included are published, the systematic review does not need ethical approval. CRD42020160801.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 3 区 医学:内科
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
JCR分区:
出版当年[2018]版:
Q2 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q2 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [a]Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Shenzhen, Guangdong Province, [*1]Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Futian District, Shenzhen, Guangdong 518000, China
共同第一作者:
通讯作者:
通讯机构: [a]Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Shenzhen, Guangdong Province, [*1]Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, 6001 Beihuan Avenue, Futian District, Shenzhen, Guangdong 518000, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号